A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Mercury Bio, a biotechnology company advancing large-molecule therapeutics for neurodegenerative disease, and Meta-Flux, an AI-powered disease simulation company, have announced a strategic ...

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer's disease.

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

Alzheimer’s is often diagnosed late in the course of the disease, which is why researchers have been investigating whether a ...

Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Research published in the Journal of Alzheimer's Disease suggests findings could transform emergency protocols for the 2.5 ...